Phase Holographic
PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024
PHI is delighted to participate in the Redeye Regenerative Medicine and Cell Therapy event on Wednesday, February 14, 2024. As a pioneering force in medical technology, PHI specializes in developing advanced microscope-based research instruments that revolutionize the study of living cell cultures. PHI's non-invasive cell imaging and analysis method is considered one of the very few methods that have the potential to become standards for the quality, safety and democratization of future cell therapies.
PHI's CEO, Patrik Eschricht, will showcase the company’s latest advancements and detail how the company is uniquely positioned to contribute to the rapidly growing field of regenerative medicine and cell therapy research.
Date: February 14, 2024
Time: 09.10 AM
Watch live: https://www.redeye.se/events/966283/redeye-theme-cell-therapy
| Datum | 2024-02-07, kl 14:56 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!